New hope for a type 2 diabetes cure
- Details
- Category: Research
The cancer treatment drug Imatinib, otherwise known as Gleevec is approved to treat various forms of cancer, mostly notably chronic myeloid leukemia (CML). However, researchers have stumbled onto another possible use for it, curing type 2 diabetes. The team - made up of scientists from the Scripps Research Institute in United States, South Korea-based company Hyndai Pharm Co., Ltd., the Seoul National University, and Ulsan National Institute of Science and Technology (UNIST)
Scientists resurrect an abandoned drug, find it effective against human viruses
- Details
- Category: Research
Viruses have proven to be wily foes. Attempts to fend off viruses causing even the common cold or flu have failed, and new viral outbreaks such as dengue, Ebola or Zika continue to elude drugs. Given these challenges, a group at Stanford is tackling the problem from a different angle: boosting the human body's ability to resist the virus rather than taking on the virus directly.
Encouraging foundation for upcoming AIDS vaccine clinical trial
- Details
- Category: Research
Some people infected with HIV naturally produce antibodies that effectively neutralize many strains of the rapidly mutating virus, and scientists are working to develop a vaccine capable of inducing such "broadly neutralizing" antibodies that can prevent HIV infection.
Increased vitamin C in the diet could help protect against cataracts
- Details
- Category: Research
Higher dietary intake of vitamin C has been found to have a potentially preventative effect on cataract progression in the first twin study of cataracts to examine to what degree genetic and environmental factors influence their progression with age. Cataract is a common condition in which the lens of the eye becomes cloudy as a result of oxidation over time.
Nanoparticle-based cancer therapies shown to work in humans
- Details
- Category: Research
A team of researchers led by Caltech scientists have shown that nanoparticles can function to target tumors while avoiding adjacent healthy tissue in human cancer patients. The findings, published online this week in the journal Proceedings of the National Academy of Sciences, demonstrate that nanoparticle-based therapies can act as a "precision medicine" for targeting tumors while leaving healthy tissue intact.
Getting closer to using beer hops to fight disease
- Details
- Category: Research
Hops, those little cone-shaped buds that give beer its bitter flavor, pack a surprisingly healthful punch. They are widely studied for their ability to halt bacterial growth and disease. Now, researchers report that they are close to synthesizing the healthful hops compounds in the lab.
Common painkillers are more dangerous than we think
- Details
- Category: Research
Many Danes are prescribed NSAIDs for the treatment of painful conditions, fever and inflammation. But the treatment also comes with side effects, including the risk of ulcers and increased blood pressure. A major new study now gathers all research in the area. This shows that arthritis medicine is particularly dangerous for heart patients, and also that older types of arthritis medicine,
More Pharma News ...
- 3-D technology enriches human nerve cells for transplant to brain
- Using generic cancer drug could save many millions of dollars
- Scientists create painless patch of insulin-producing beta cells to control diabetes
- Heart attacks could be reduced by rethinking the way we prescribe statins
- Widely used kidney cancer drugs can't stop recurrence
- Turn off the Alzheimer's disease
- Wolters Kluwer offers free online access to support the fight against the Zika virus